Variant VKORC1 and CYP2C9 Alleles in Patients with Diffuse Alveolar Hemorrhage Caused by Oral Anticoagulants

By Wijnen Petal A.   Linssen Catharina F.   Haenen Guido R.   Bekers Otto   Drent Marjolein  

Molecular Diagnosis & Therapy, Vol. 14, Iss. 1, 2010-02 ,pp. : 23-30

Adis International

Access to resources Recommend Favorite

High carrier prevalence of combinatorial CYP2C9 and VKORC1 genotypes affecting warfarin dosing

By Ruañño Gualberto   Thompson Paul D   Villagra David   Bower Bruce   Kocherla Mohan   Yazdanpanah Golriz   Seip Richard L   Windemuth Andreas   White C Michael   Duconge Jorge   Holford Theodore R   Wu Alan HB  

Personalized Medicine, Vol. 5, Iss. 3, 2008-05 ,pp. : 225-232

Future Medicine

Access to resources Recommend Favorite

Platform evaluation for rapid genotyping of CYP2C9 and VKORC1 alleles

By Joshi Victoria A   Duffy Elizabeth   Funke Birgit H   Farwell Lisa M   Mancini-Dinardo Debora   Kucherlapati Raju  

Personalized Medicine, Vol. 6, Iss. 4, 2009-07 ,pp. : 449-457

Future Medicine

Access to resources Recommend Favorite

Effect of CYP2C9–VKORC1 interaction on warfarin stable dosage and its predictive algorithm

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 3, 2015-03 ,pp. : 251-257

John Wiley & Sons Inc

Access to resources Recommend Favorite

Distribution of CYP2C9 and VKORC1 Risk Alleles for Warfarin Sensitivity and Resistance in the Israeli Population

By  

Current Drug Safety, Vol. 5, Iss. 3, 2010-01 ,pp. : 190-193

Bentham Science Publishers

Access to resources Recommend Favorite